MedPath

A randomised controlled trial of treatment with SSRI or SNRI for patients with functional (psychogenic) dizziness

Not Applicable
Conditions
functional (psychogenic) dizziness
Registration Number
JPRN-UMIN000031958
Lead Sponsor
Department of Psychosomatic Medicine, Toho University School of Medicine
Brief Summary

Thirteen people participated, but 10 people were included in the analysis due to dropouts. As for changes after 4 weeks, CGI and VSS-sf improved in all patients in the escitalopram group, showing a statistically significant decreasing tendency. No significant changes were observed after 4 weeks in the control group and the milnacipran group.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
13
Inclusion Criteria

Not provided

Exclusion Criteria

Subjects are excluded if they express suicidal ideation. Other exclusion criteria are currently undergoing treatment with antidepressants or no understanding ability of this study themselves, or no intention of participation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath